Blood Cancer Talks

In this episode, Dr. Matt Kalaycio breaks down the complexities of donor selection and HLA-matching in allogeneic hematopoietic stem and progenitor cell transplantation.

Show Notes

Key papers discussed in the show:
1. Landmark paper on HLA-mismatch and survival:
2. HLA-DP and Risk of GVHD:
3. Outcomes of Allogeneic Transplant with HLA-Mismatched Unrelated Donor:
4. Review/perspective on fundamentals of unrelated donors and cord blood units:
5. HLA-DQ heterodimers and HCT:
6. PT-Cy as GVHD prophylaxis after HCT:
7. Comparative outcome of MUD vs Haplo-HCT from Registry data:

What is Blood Cancer Talks?

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk